Biotech Firm Allocates $700M to Buy BNB
-
最新报道：Biotech firm Amgen has allocated $700 million to purchase Binance Coin (BNB) as part of its treasury diversification strategy. The move signals growing institutional interest in crypto assets beyond Bitcoin and Ethereum. Amgen's CFO stated the investment reflects confidence in BNB's utility within the Binance ecosystem and its long-term growth potential. The purchase will be executed over several months to minimize market impact. This marks one of the largest corporate allocations to a single altcoin by a non-crypto native company.
下一篇
Tron Files With SEC for $1 Billion Mixed Shelf Offering
- TRON founder Justin Sun has refuted SEC allegations of unregistered securities offerings, ...
24小时热点
热点专题
407297